The trough levels of bevacizumab significantly affect the outcome of the treatment in patients with metastatic colorectal cancer: A Turkish Oncology Group study.

AKBULUT H., Ocal M., Sonugur F. G., Abgarmi S. A., BABAHAN C., Akay B., ...Daha Fazla

JOURNAL OF CLINICAL ONCOLOGY, cilt.36, sa.15, 2018 (SCI-Expanded) identifier